The AIBL study announces the release of PiB and MRI images and corresponding ADNI compliant clinical and psychometric data for the three year follow-up time point of the AIBL study. Three year clinical data is now available on 221 participants imaged at baseline and three year imaging data is available on 177 of these participants. Of these, 152 had MR, 173 had PiB PET, and  148 had  PiB PET and MR. Funding to support this data release was provided by the Alzheimer’s Association. AIBL gratefully acknowledges the support of the Science Industry Endowment Fund, CSIRO, NHMRC, Alzheimer’s Association, Alzheimer Drug Discovery Foundation, an anonymous donor, GE Healthcare, Bayer, Piramal, Avid Radiopharmaceuticals, Pfizer and Astra Zeneca.